330 related articles for article (PubMed ID: 24981297)
1. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
3. The role of HPV in head and neck cancer and review of the HPV vaccine.
D'Souza G; Dempsey A
Prev Med; 2011 Oct; 53 Suppl 1(Suppl 1):S5-S11. PubMed ID: 21962471
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives.
Wierzbicka M; Berkhof JH; Dikkers FG
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):85-90. PubMed ID: 30694913
[TBL] [Abstract][Full Text] [Related]
6. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
7. The Expanded Impact of Human Papillomavirus Vaccine.
Pahud BA; Ault KA
Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
[TBL] [Abstract][Full Text] [Related]
8. [The first vaccine against cancer: the human papillomavirus vaccine].
Bősze P
Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
[TBL] [Abstract][Full Text] [Related]
9. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
[TBL] [Abstract][Full Text] [Related]
10. Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.
Fruscalzo A; Londero AP; Bertozzi S; Lellè RJ
Minerva Med; 2016 Feb; 107(1):26-38. PubMed ID: 26473283
[TBL] [Abstract][Full Text] [Related]
11. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.
Dasbach EJ; Elbasha EH; Insinga RP
Epidemiol Rev; 2006; 28():88-100. PubMed ID: 16740585
[TBL] [Abstract][Full Text] [Related]
14. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
15. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
18. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons.
Malloy KM; Ellender SM; Goldenberg D; Dolan RW
JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1037-42. PubMed ID: 23989246
[TBL] [Abstract][Full Text] [Related]
19. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
Chatterjee A
Expert Rev Vaccines; 2014 Nov; 13(11):1279-90. PubMed ID: 25256262
[TBL] [Abstract][Full Text] [Related]
20. The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.
Jackowska J; Bartochowska A; Karlik M; Wichtowski M; Tokarski M; Wierzbicka M
PLoS One; 2015; 10(10):e0141003. PubMed ID: 26501885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
